Jarrad Mattieu Aguirre sold $4K of Lyell Immunopharma stock
By AlphaYouPublished Form 4
Aguirre Jarrad Mattieu
Reporting filer
Jarrad Mattieu Aguirre reported selling 422 shares of Lyell Immunopharma, Inc. for about $4K ($8.63 a share on average). Form 4 filed Oct 13, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 13, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Aguirre Jarrad Mattieu | 2026-10-12 | S | Sale | 422 | 8.63 | 19,857 | 1 day | Filed terms
|
Common Stock
- Owner
- Aguirre Jarrad Mattieu
- Date
- 2026-10-12
- Code
- S
- Action
- Sale
- Quantity
- 422
- Price
- 8.63
- Following holdings
- 19,857
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 422
- id: F1
- transaction Price Per Share: 8.63
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 19857
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Aguirre Jarrad Mattieu: Chief Medical Officer.
- F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
- F2: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $8.54 to $8.63 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.